了解跨性别者的心血管疾病：征程仍在继续。 - Suppr | 超能文献

Understanding cardiovascular disease among transgender people: the journey continues.

作者信息

Goodman Michael

机构信息

Emory University Rollins School of Public Health 1518 Clifton Road, NE, Atlanta, GAUSA.

出版信息

Eur J Prev Cardiol. 2022 Nov 8;29(15):2015-2016. doi: 10.1093/eurjpc/zwac182.

DOI:10.1093/eurjpc/zwac182

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Understanding cardiovascular disease among transgender people: the journey continues.了解跨性别者的心血管疾病：征程仍在继续。

Eur J Prev Cardiol. 2022 Nov 8;29(15):2015-2016. doi: 10.1093/eurjpc/zwac182.

2

Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk.性别认同、激素治疗与心血管疾病风险。

Curr Probl Cardiol. 2020 May;45(5):100396. doi: 10.1016/j.cpcardiol.2018.09.003. Epub 2018 Sep 20.

3

Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.瑞典开始性别肯定激素治疗后跨性别个体的心血管结局。

Eur J Prev Cardiol. 2022 Nov 8;29(15):2017-2026. doi: 10.1093/eurjpc/zwac133.

4

The heart of the matter: balancing potential cardiovascular risks with known benefits of gender-affirming testosterone.问题的核心：在性别肯定性睾酮疗法已知的益处与潜在的心血管风险之间取得平衡。

Fertil Steril. 2021 Feb;115(2):334-335. doi: 10.1016/j.fertnstert.2020.11.032. Epub 2021 Jan 6.

5

Cardiometabolic Outcomes in Transgender Youth.跨性别青少年的心脏代谢结局

J Clin Endocrinol Metab. 2022 Nov 25;107(12):e4380-e4381. doi: 10.1210/clinem/dgac592.

6

Cardiovascular Disease in a Population-Based Sample of Transgender and Cisgender Adults.基于人口的跨性别和顺性别成年人样本中的心血管疾病。

Am J Prev Med. 2021 Dec;61(6):804-811. doi: 10.1016/j.amepre.2021.05.019. Epub 2021 Aug 5.

7

Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014-2017 BRFSS.评估美国成年人心血管疾病中的性别认同差异：来自 2014-2017 年 BRFSS 的数据分析。

J Behav Med. 2020 Apr;43(2):329-338. doi: 10.1007/s10865-019-00102-8. Epub 2019 Sep 26.

8

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.跨性别成年人的性别肯定激素治疗、血管健康和心血管疾病。

Hypertension. 2019 Dec;74(6):1266-1274. doi: 10.1161/HYPERTENSIONAHA.119.13080. Epub 2019 Oct 28.

9

Association of Media Coverage on Transgender Health With Referrals to Child and Adolescent Gender Identity Clinics in Sweden.媒体对跨性别者健康报道与瑞典儿童和青少年性别认同诊所转介的关联。

JAMA Netw Open. 2022 Feb 1;5(2):e2146531. doi: 10.1001/jamanetworkopen.2021.46531.

10

Response to Letter to the Editor: "Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared to Cisgender Youth".对致编辑信的回复：“与顺性别青少年相比，跨性别青少年的身体成分和心脏代谢健康标志物”

J Clin Endocrinol Metab. 2020 Mar 1;105(3):e919. doi: 10.1210/clinem/dgaa020.

引用本文的文献

1

Emerging and accumulating safety signals for the use of estrogen among transgender women.跨性别女性使用雌激素出现并不断积累的安全信号。

Discov Ment Health. 2025 Jun 12;5(1):88. doi: 10.1007/s44192-025-00216-3.

2

Participation of transgender and gender diverse persons in cardiovascular clinical trials.跨性别者和性别多样化者参与心血管临床试验。

Am Heart J Plus. 2024 Jul 3;44:100420. doi: 10.1016/j.ahjo.2024.100420. eCollection 2024 Aug.